EU – Western Balkans Dialogue on Drugs

The Dialogue between the European Union and the countries of the Western Balkans on drugs will be held on 25 May 2023 in Brussels. The European side is coordinated by the Swedish Presidency of the European Union. Representatives of the national drug agencies of the EU countries who cooperate within the Horizontal Drug Group (HDG), the body of the Council of the European Union responsible for leading and managing the work of the Council and the European Union on policy, will participate. The embassies of the countries of the Western Balkans to the European Union are invited to the Dialogue.

The Civil Society Forum on Drugs of the European Union (CSFD), an expert group at the European Commission consisting of 45 civil society organizations from all over Europe, representing a variety of fields of drug policy, and a variety of stances within those fields, prepared the document with information, views and recommendations of civil society. Several civil society organizations from the region participated in its preparation. DPNSEE, as a CSFD member organization, coordinated the collection of their contributions. The document has been sent to the Swedish EU Presidency and will be distributed to HDG members and embassies.

The CSFD document is available following this link>>>.

We hope that it will have an impact and contribute to better and coordinated partnerships and support to the region.

A New EU Drug Strategy is Being Prepared by the German Presidency

The 2021-25 EU Drugs Agenda recently published by the European Commission was criticised by civil society and member states. We have already posted comments from Péter Sárosi, the executive director of the Rights Reporter Foundation and an article about the sign-on letter of the International Drug Policy Consortium’s (IDPC) members, raising our very serious concerns regarding the new 2021-25 EU Agenda and Action Plan on Drugs.

The Civil Society Forum on Drugs (CSFD) also criticised the Agenda in its position paper for its stigmatising language and framework, lack of balanced approach, reduced role for harm reduction, decreased relevance of human rights and several other reasons.

Member States did not accept the new EU Drugs Agenda proposed by the EU Commission. The Horizontal Working Party on Drugs (HDG) decided that a new EU strategy will be prepared by the German presidency.

To read more about the positions of the CSFD, follow this link>>> to the article on the Rights Reporter Foundation website.